Innospec (IOSP)
(Delayed Data from NSDQ)
$130.22 USD
+2.12 (1.65%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $130.47 +0.25 (0.19%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$130.22 USD
+2.12 (1.65%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $130.47 +0.25 (0.19%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth C Momentum B VGM
Zacks News
Bunge (BG) to Acquire 49% of BZ Group to Expand in Europe
by Zacks Equity Research
Bunge (BG) entered a strategic partnership with BZ Group to buy a 49% stake in the latter to expand its presence in Western Europe.
First Majestic (AG) to Sell Its Royalty Portfolio for $20M
by Zacks Equity Research
First Majestic (AG) has entered into an agreement with Metalla to sell eight precious metals royalties for a deal value of $20 million.
GrowGeneration (GRWG) Grows Base With 1st Store in New Jersey
by Zacks Equity Research
GrowGeneration (GRWG) launches its first store in New Jersey to widen its reach to 16 states and further strengthen its operations.
Is Innospec (IOSP) Stock Outpacing Its Basic Materials Peers This Year?
by Zacks Equity Research
Here is how Innospec (IOSP) and Commercial Metals (CMC) have performed compared to their sector so far this year.
Innospec (IOSP) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Innospec (IOSP) delivered earnings and revenue surprises of 24.29% and 9.53%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Cabot (CBT) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Cabot (CBT) delivered earnings and revenue surprises of 4.73% and 7.16%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Why You Should Buy Sociedad Quimica (SQM) Stock Right Now
by Zacks Equity Research
Sociedad Quimica (SQM) benefits from higher realized prices, strength in its lithium business and strong demand.
Here's Why You Should Hold Onto Chemours (CC) Stock for Now
by Zacks Equity Research
While Chemours (CC) is exposed to supply-chain issues and higher input costs, it gains on healthy demand, strong execution and its cost-reduction and pricing actions.
Cabot's (CBT) Shares Up 17% YTD: What's Driving the Stock?
by Zacks Equity Research
Cabot (CBT) gains on strong underlying demand across its businesses, its disciplined execution of operations and strategic acquisition.
Is CSW Industrials (CSWI) Outperforming Other Basic Materials Stocks This Year?
by Zacks Equity Research
Here is how CSW Industrials (CSWI) and Innospec (IOSP) have performed compared to their sector so far this year.
Albemarle's (ALB) Shares Pop 21% in 3 Months: Here's Why
by Zacks Equity Research
Albemarle (ALB) gains on higher demand and prices in its lithium business and actions to boost its global lithium conversion capacity.
Zacks Industry Outlook Highlights Albemarle, The Chemours, Univar Solutions and Innospec
by Zacks Equity Research
Albemarle, The Chemours, Univar Solutions and Innospec have been highlighted in this Industry Outlook article.
4 Stocks to Buy From the Prospering Diversified Chemical Industry
by Anindya Barman
A recovery in demand in major end markets should enable the Zacks Chemicals Diversified industry to thrive. ALB, CC, UNVR and IOSP are set to gain from favorable industry fundamentals and strategic actions to counter cost inflation.
Linde (LIN) to Build Electrolyzer to Boost Hydrogen Production
by Zacks Equity Research
The project is likely to increase Linde's (LIN) green liquid hydrogen production capacity in the United States more than twice.
Down 9.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Innospec (IOSP)
by Zacks Equity Research
Innospec (IOSP) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Linde (LIN) Inaugurates Hydrogen Refueling System in Germany
by Zacks Equity Research
Linde (LIN) says that the development is signaling its strong initiative in playing a significant role in decarbonizing transport in Europe.
Can Innospec (IOSP) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
Innospec (IOSP) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Innospec (IOSP) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Innospec (IOSP) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Innospec (IOSP) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Innospec (IOSP) delivered earnings and revenue surprises of 19.70% and 6.16%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Air Products and Chemicals (APD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Air Products and Chemicals (APD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Innospec (IOSP) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Innospec (IOSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is American Vanguard (AVD) Outperforming Other Basic Materials Stocks This Year?
by Zacks Equity Research
Here is how American Vanguard (AVD) and Innospec (IOSP) have performed compared to their sector so far this year.
Innospec (IOSP) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Innospec (IOSP) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Is Steel Dynamics (STLD) Outperforming Other Basic Materials Stocks This Year?
by Zacks Equity Research
Here is how Steel Dynamics (STLD) and Innospec (IOSP) have performed compared to their sector so far this year.
Are You Looking for a Top Momentum Pick? Why Innospec (IOSP) is a Great Choice
by Zacks Equity Research
Does Innospec (IOSP) have what it takes to be a top stock pick for momentum investors? Let's find out.